Shengli Meng 孟胜利

Deputy Director, Wuhan Institute of Biological Products, Research Centre, Sinopharm Group

国药集团中国生物武汉生物制品研究所副主任

Mr. Shengli Meng was Doctor of Immunology at Wuhan Institute of Biological Products from 2004-2010.  From 2010 to now, he has been the Deputy Director of Wuhan Institute of Biological Products.

 

He participated in the development of "2019-NCOV inactivated vaccine”.  Publications include articles and books for international and domestic magazines.

 

Mr. Meng is also an editorial board member of international Journal of Biological Products; evaluation expert of Wuhan Science and Technology Bureau; expert of Chinese biological quality management; and has more than 10 years of experience in virus and vaccine related research. He is also familiar with the development progress and technical path of domestic vaccine.

2004-2010年,武汉生物制品研究所,免疫学博士

2010-至今,一直任职于武汉生物制品研究所,目前为研究所副主任

重点研究成果:参与开发 “2019-nCov灭活疫苗”

著作包括多篇国际国内杂志的文章和书籍

国际生物制品学杂志编委、武汉市科技局评审专家、中国生物质量管理专家

10年以上的病毒、疫苗相关研究经验,可以聊国内疫苗的研发进展,技术路径等。

Copyright © 2020 Nomura

This website is the sole property of Nomura. No part of this website may be reproduced in any form of by any means - electronic, mechanical, photocopying, recording or otherwise - without the prior written permission of Nomura.